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Abstract
Background: Adaptation to hypoxia and consequent pro-inflammatory gene expression of prostate and breast
carcinomas have been implicated in the progression toward cancer malignant phenotype. Only partial data are
available for the human tumor glioblastoma multiforme (GBM). The aim of our study was to analyze the hypoxic
and pro-inflammatory microenvironment in GBMs and to demonstrate that in a stem/progenitor cell line derived
from human glioblastoma (GBM-SCs), hypoxia activates a coordinated inflammatory response, evidencing an
invasive and migratory phenotype.
Methods: From each of 10 human solid glioblastomas, clinically and histopathologically characterized, we obtained
three surgical samples taken from the center and the periphery of the tumor, and from adjacent host normal
tissue. Molecular and morphological analyses were carried out using quantitative real-time PCR and western blot
(WB). GBM stem and differentiated cells were incubated under hypoxic conditions and analyzed for pro-
inflammatory gene expression and for invasive/migratory behavior.
Results: A panel of selected representative pro-inflammatory genes (RAGE and P2X7R, COX2, NOS2 and, PTX3)
were analyzed, comparing tumor, peritumor and host normal tissues. Tumors containing leukocyte infiltrates (as
assessed using CD45 immunohistochemistry) were excluded. Selected genes were overexpressed in the central
regions of the tumors (i.e. in the more hypoxic areas), less expressed in peripheral regions, and poorly expressed
or absent in adjacent normal host tissues. Western blot analysis confirmed that the corresponding pro-
inflammatory proteins were also differently expressed. Hypoxic stem cell lines showed a clear time-dependent
activation of the entire panel of pro-inflammatory genes as compared to differentiated tumor cells. Biological
assays showed that invasive and migratory behavior was strengthened by hypoxia only in GBM stem cells.
Conclusions: In human solid glioblastoma we have observed a coordinated overexpression of a panel of pro-
inflammatory genes as compared to host normal tissue. We have also evidenced a similar pattern of overexpressed
genes in GBM-SCs after hypoxic treatment, showing also a gain of invasive and migratory function that was lost
when these stem cells differentiated. We suggest that, as has been previously described for prostatic and
mammary carcinoma, in human glioblastoma acquisition of a proinflammatory phenotype may be relevant for
malignant progression.
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Glioblastoma multiforme (GBM) is the most common
and malignant type of brain tumor in adults and is char-
acterized on histologic examination according to hyper-
cellularity, nuclear atypia, mitotic figures, and evidence
of angiogenesis and/or necrosis. The median survival for
patients with GBM tumors is 12-18 months and the
majority of these patients die within two years [1-3].
The current standard of care for GBM begins with max-
imal safe surgical resection followed by a combination
of radiotherapy (RT) with temozolomide therapy [2].
GBM is characterized by invasiveness, necrosis and
angiogenesis. In particular, vascular proliferation is an
important aspect of GBM and correlates with the grade
and aggressiveness of the tumor [4,5]. The increased
vascular proliferation is thought to depend on hypoxic
conditions created by the elevated growth rate of GBM.
Increasing tumor size requires that GBM tumor cells
maintain a balance between adaptation to hypoxia and
cell death (apoptosis and central necrosis) through
activation of hypoxia-inducible transcription factor 1
(HIF-1). HIF-1 is a heterodimeric protein composed of
two subunits, a and b.U n d e rn o r m o x i aH I F - 1 a is
degraded by the ubiquitin-proteasome system, but when
the intracellular oxygen concentration drops, HIF-1a is
stabilized and translocates to the nucleus where it binds
to HIF-1b [6]. The HIF-1a and b dimer activates tran-
scription of genes involved in angiogenesis, glucose
transport, apoptosis resistance, metastasis, inflammation,
etc [7,8]. Such activation of transcription is achieved by
binding of HIF-1a to hypoxia-responsive elements
(HREs) located on the promoters of target genes [9].
We have shown recently that in breast and prostate
tumors, as well as in breast tumor cell lines, HIF-1a has
a crucial role in regulating, either directly or indirectly,
the expression of pro-inflammatory genes. The pro-
inflammatory molecules we have analyzed include
membrane receptors for damage associated molecular
patterns (DAMPs) such as RAGE and P2X7R, inducible
enzymes such as COX2 and NOS2, and acute phase pro-
teins such as PTX3 [10,11]. Furthermore, we have
demonstrated that hypoxia increases the expression of
chemokine (C-X-C motif) receptor 4 (CXCR4) which, in
turn, stimulates migration of tumor cells in an in vitro
assay [11]. Therefore, we sought to understand if in
GBM, in which hypoxic conditions are well documented
and important for tumor adaptation, we could observe an
up-regulation of the same pro-inflammatory molecules
analyzed in other tumors. In particular, surgical resec-
tions of cerebral GBM were achieved by craniotomy and
with the aid of multiple data sets of advanced neuroima-
ging techniques loaded and eventually merged on the
neuronavigation system used during surgery. For the
purpose of this study, we merged the grid of spectroscopy
MRI with T1 contrast-weighed volumetric MRI on the
neuronavigation workstation, and preoperatively selected
in this grid the neuropathological samples to harvest.
Samples were selected from within the tumor, and in
nonfunctional areas from peritumor and surrounding
host tissue. In this way, we were able to study the expres-
sion of pro-inflammatory molecules in three separate
samples: tumor, peritumor and surrounding host tissue.
Recently, tumor stem cells have been isolated from
GBMs [12]. These tumor stem cells grow as neurospheres,
possess the capacity for self-renewal, and differentiate into
phenotypically diverse populations of cells similar to those
present in the initial GBM. Furthermore, only these tumor
stem cells are able to form tumors and generate both neu-
rons and glial cells after in vivo implantation into nude
mice [13,14]. In fact, cancer stem cells have been reported
to be the only tumorigenic population in GBM, their
unlimited proliferative potential being required for tumor
development and maintenance [15]. Therefore, in this
study we sought to determine if isolated tumor stem cells
from GMB express pro-inflammatory proteins and if such
expression is increased by hypoxia.
In conclusion, our study demonstrates that GBMs
express pro-inflammatory proteins and that such expres-
sion is almost exclusively localized in tumor tissue, and
less so in peritumor or host tissue. We also demonstrate
that tumor stem cells isolated from GBM and incubated
under hypoxia have a similar overexpression of pro-
inflammatory proteins with increased invasion and
migration.
Methods
Patients
Ten patients affected by cerebral GBM, as confirmed by
neuropathological examination, who submitted to gross
total removal of the tumor with the aid of neuronaviga-
tion and intraoperative neurophysiological monitoring,
were included in this study. All patients were preopera-
tively submitted to functional, spectroscopy and T1 con-
trast-weighed volumetric MRI. No histological samples
were harvested in functional areas according to both
preoperative neuroradiological exams and intraoperative
neurophysiological monitoring. Cases in which brain
shift occurred at the dura opening were not included in
this study because navigation was not considered reli-
able and consequently samples were not harvested with
the stereotactic needle. All patients gave their informed
consent for the study.
Neuronavigation procedure
A 1.5-T clinical whole-body MR imager using polarized
head coil and a gradient field strength of 44 mT/m with
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Page 2 of 16124 T/m/s rise time was used. Spectroscopy was acquired
with spin echo sequences (TR = 2000, TE = 135 and 30
ms) and with variable matrix (according to the site of the
lesion). Postprocessing of the spectroscopic data was per-
formed using a LCModel
® f o rL i n u x :f i l t e r i n g ,a p o d i z a -
tion, phase correction and curve fitting of the main
cerebral metabolites: N-acetyl aspartate, creatine, cho-
line, lactate (when present) and myo-inositol in spectra
with short TE. Ratios and maps of the above-mentioned
molecules were created. The spectroscopic Cho/NAA
ratio was evaluated in all voxels of an axial slice prede-
termined during the MRI examination. A grid of voxels
with the numerical value of the ratios was superimposed
over the corresponding slice of the volumetric structural
dataset. The final exam was reconverted in DICOM for-
mat to be imported into the neuronavigation central
unit. Here, the modified spectroscopic sequence was
merged with a classical sequence without the grid: once
the targets have been selected in the Navigator worksta-
tion, the grid can be suppressed (modifying the blend
settings) in order not to obstruct the view of the
surgeon while performing the biopsy. Each sample was
surgically taken from its respective target with the aid
of frameless stereotaxy (based on the Navigation tech-
nology), and subsequently harvested for molecular and
histological analysis.
Isolation, culture and differentiation of glioblastoma
spheres
Tumor samples were obtained in accordance with con-
sent procedures approved by the Institutional Review
Board of the Department of Neurosurgery, Catholic
University, Rome, Italy. Undifferentiated glioblastoma
cells were obtained as previously described [16]. Briefly,
surgical specimens were washed several times in
DMEM-F12 medium supplemented with high doses of
penicillin/streptomycin and amphotericin B to avoid
contamination. Mechanical tissue dissociation was car-
ried out in order to obtain single cell suspensions.
Recovered cells were cultured in serum-free medium
containing 50 mg/ml insulin, 100 mg/ml apo-transferrin,
10 mg/mlputrescine, 0.03 μM sodium selenite, 2 mM
progesterone, 0.6% glucose, 5 mM HEPES, 0.1% sodium
bicarbonate, 0.4% BSA, glutamine and antibiotics, dis-
solved in DMEM-F12 medium (Gibco-Invitrogen) and
supplemented with 20 mg/ml EGF and 10 mg/ml bFGF.
Flasks non-treated for tissue culture were used to reduce
cell adherence and to support cell growth as undifferen-
tiated tumor spheres. The medium was replaced or sup-
plemented with fresh growth factors twice a week until
the cells started to grow forming floating aggregates.
Cultures were expanded by mechanical dissociation of
spheres into small aggregates, followed by cell re-plating
in complete fresh medium.
Differentiation of tumor stem cells was achieved by
seeding dissociated cells in treated flasks in DMEM-F12
supplemented with 10% FBS. Attached cells were kept
in the flasks for 1 week before performing the experi-
ments herewith reported.
Real-time quantitative polymerase chain reaction (RT-PCR)
Samples (cells or tissue) were lysed to extract total RNA
with a BioRobot EZ1 workstation (Qiagen, Milan Italy).
Approximately 1 μg of RNA was reverse-transcribed
using a High-Capacity cDNA Archive Kit (Applied Bio-
systems, Milan, Italy) following the manufacturer’s
instructions. Aliquots of cDNA were subjected to real
time PCR in 50 μlo f1×U n i v e r s a lP C RM a s t e rM i x ,
0.5 μM TaqMan probe and 5 ng of cDNA. Primers and
probes for HIF-1a, NF-kB, P2X7R, RAGE, NOS2,
COX2, PTX3, CXCR4, VEGF, were designed using
Assays on-Demand facility (Applied Biosystems). Each
sample was loaded in triplicate, and negative and posi-
tive controls were included. Amplification of 18S rRNA
was used as internal reference gene. PCR amplifications
were performed as follows: 50°C for 2 minutes, 95°C for
10 minutes, and 40 cycles each with 95°C for 15 seconds
and 60°C for 1 minute using an ABI PRISM 7000
sequence detector (Applied Biosystems). Amplification
data were analyzed using Sequence Detector version 1.7
software (Applied Biosystems). Statistical analysis of
real-time PCR results were done using mean normalized
cycle threshold (ΔCt) values and the pooled standard
deviation of the mean ΔCt. Experiments were repeated
at least 3 times with different preparations.
Immunohistochemistry
Sections were deparaffinazed and rehydrated through a
graded series of xylene-ethanol and then incubated for
15 minutes in 3% hydrogen peroxide to inhibit endogen-
ous peroxidases. Antigen retrieval was performed by
boiling slides for 15 minutes in citrate buffer. Tissue
sections were incubated with the primary antibody, anti-
Ki67, for 1 h at room temperature. Sections were then
incubated with biotinylated secondary antibody for 20
minutes at room temperature followed by 20 minutes
incubation with avidin-biotin peroxidase complex
(DAKO, Milan, Italy). Visualization was performed using
3,3 diaminobenzidine. Tissue sections were counter-
stained with hematoxylin, dehydrated and mounted.
Western blot assay
Cells were pelleted at 700 × g (5 min at 4°C) and lysed in
50 μlo fc e l ll y s i sb u f f e r( 2 0m MT r i s ,p H7 . 4 ,1 0 0m M
NaCl, 1% Triton, 1 mM phenylmethylsulfonyl fluoride,
10 μg/ml leupeptin, 10 μg/ml aprotinin). Alternatively,
fresh frozen tissues were resuspended in a suitable
volume of lysis buffer and homogenized. Afterwards,
Tafani et al. Journal of Neuroinflammation 2011, 8:32
http://www.jneuroinflammation.com/content/8/1/32
Page 3 of 16lysates were clarified by centrifugation (10 min at 4°C)
and the supernatant collected. Protein concentration
was determined by the Bradford assay (Bio-Rad).
Equivalent amounts of protein were electrophoresed on
SDS-polyacrylamide gels. The gels were then electro-
blotted onto PVDF membranes. After blocking with 5%
milk, membranes where incubated with the primary
antibody overnight. Finally, the relevant protein was
visualized by staining with the appropriate secondary
horseradish peroxidase-labeled antibody for 1 hour fol-
lowed by enhanced chemiluminescence. Densitometric
scanning analysis was performed by Mac OS 9.0 (Apple
Computer Int), using NIH Image 1.62 software.
Antibodies
T h ef o l l o w i n gp r i m a r ya n t i b o d i e sw e r eu s e d :m o u s e
anti-Ki67 (MIB-1) (DAKO), mouse anti-HIF-1a,m o u s e
anti-CXCR4, mouse anti-Lamin A/C (BD Bioscience,
San Jose, CA), rabbit anti-NOS2, mouse anti-CD45, rab-
bit anti P2X7R, goat anti-RAGE, rabbit anti-NF-kB p65,
(Santa Cruz Biotechnology, Santa Cruz, CA), rabbit
anti-PTX3 (Alexis Biochemical, San Diego, U.S.A.), rab-
bit anti-COX2 (Cayman Chemical, Ann Arbor, MI),
mouse anti-b-actin (Sigma-Aldrich, St Louis, MO),
CD133 PE (Militenyi Biotec, Bergisch Gladbach,
Germany), and glial fibrillary acific protein (GFAP)
(DAKO). The following secondary antibodies were used:
anti-mouse Alexa 488, (Invitrogen-Molecular Probes,
E u g e n e ,O r e g o n ) ,m o u s ea n t i - r a b b i tH R P ,g o a ta n t i -
mouse HRP (Amersham Biosciences, Piscataway, NJ),
and donkey anti-goat HRP (Santa Cruz).
Hypoxia
Hypoxic conditions were achieved by incubating glio-
blastoma stem cells in a hypoxia chamber (Billups-
Rothenberg Inc. CA) where a 1% oxygen mix was
flushed in for 4 minutes according to the manufacturer’s
instructions.
Flow cytometry
Tumor spheres were dissociated as single cells, washed
and incubated with the PE conjugated anti-CD133 anti-
body. After a 45-min incubation, cells were washed and
analyzed with a COULTER EPICS XL flow cytometer
(Beckman Coulter, Fullerton, CA, USA).
Invasion assay
Cell invasion and migration was measured using a
24-well cell invasion assay kit from Millipore (Billerica,
MA) and following manufacturer’s instructions. Briefly,
an equivalent number of cells were resuspended in
serum free medium containing 1% BSA, seeded in an
insert and then placed inside a 24-well plate. Each well
was filled with 500 μl of serum-free medium/1% BSA.
The plate was incubated in normoxia or hypoxia for the
indicated time in the presence or absence of recombi-
nant human stromal derived factor-1a (SDF-1a)
(Thermo Fisher Scientific, Rockford IL) at a final con-
centration of 100 ng/ml. Subsequently, the insert was
placed in a staining solution. Non-invading cells at the
top of the membrane were removed. Invading cells,
from three separate experiments, at the bottom of the
membrane were stained for 10 min and then lysed. OD
values, proportional to the number of cells, were
measured on a plate reader with a 550 nm filter (Perki-
nElmer, Milan Italy).
ELISA assay on nuclear fractions
Nuclear fractions were isolated using the nuclear extrac-
tion kit from Active Motif, (Carlsbad, CA) following the
manufacturer’s instructions as previously described [17].
The relative amount of HIF-1a was measured using a
TransAM kit from Active Motif and following the man-
ufacturer’s instructions. Briefly, equivalent amounts of
protein from nuclear extracts were loaded onto a
96-well plate coated with oligonucleotides containing
HIF-1a-responsive elements. After a 1-hour incubation
at room temperature, the wells were washed 3 times
in wash buffer and incubated 1 hour with a primary
antibody at room temperature. Subsequently, the wells
were washed and incubated 1 hour with HRP-conju-
gated secondary antibody followed by addition of a
developing solution. A stop solution was added to block
the reaction and color intensity was read in a plate
reader with a 450 nm filter. The color intensity in each
well is proportional to the amount of the transcription
factor bound to the oligonucleotides.
Immunofluorescence and confocal analysis
Differentiated GBM stem cells were grown on poly-D-
lysine coated coverslips, fixed and permeabilized as
described below and then incubated with anti-GFAP
antibody. After a PBS wash, cells were incubated with
an Alexa 488-conjugated secondary antibody. Stained
cells were washed and visualized as described below.
Normoxic and hypoxic glioblastoma tumor spheres
were collected by centrifugation at room temperature
(100 × g for 2 min). After a PBS wash, tumor spheres
were included in gelatin that was solidified in ice at 4°C
for 1 h. Solid gelatin was included in OCT and 6 μm
sections obtained with a cryostat. Tumor sphere sections
were then fixed in 4% paraformaldehyde for 20 min,
washed with PBS, permeabilized for 6 min in 0.1% Tri-
ton and then incubated for 3 hours at room temperature
in the primary antibody mix (mouse anti-human HIF-1a
diluted 1:100, 1% BSA, in PBS). Afterwards, sphere sec-
tions were washed 4 times with PBS and incubated for
1 h with an anti-mouse Alexa 488 fluorescent secondary
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times and the cover slips were mounted in 50% glycerol
solution. Fluorescence intensity was visualized with a
confocal microscope (Nikon Eclipse TE 2000-E). Tumor
sphere sections were also stained with hematoxylin/
eosin as described above. The same immunofluores-
cence methodology, without sectioning, was applied for
GFAP analysis on differentiated GBM stem cells. Nuclei
were stained with DAPI (Invitrogen, Carlsbad, CA)
following the manufacturer’s instructions.
Statistical analysis
Results are expressed as mean ± standard deviation (SD)
and 95% confidence intervals (95% CI). Before using
parametric tests, the assumption of normality was veri-
fied using the Shapiro-Wilk W-test. Student’sp a i r e d
t-test was used to determine any significant differences
before and after treatment. Significance was set at p ≤
0.05. An SPSS statistical software package (SPSS Inc.,
Version 13.0.1 for Windows Chicago, IL, USA) was used
for all statistical calculations.
Results
Neuronavigation system
Figure 1 shows evaluation of the spectroscopic Cho/
NAA ratio in all voxels of a predetermined axial slice
during MRI examination. The grid of voxels represents
the numerical value of the ratios and has been superim-
posed onto the corresponding slice of the volumetric
structural dataset. Each sample was surgically taken
from its respective target based on the Cho/NAA ratio.
In particular, the Cho/NAA ratios of the samples
collected with frameless stereotaxy were considered as
follows: above 1.8 for tumoral areas (T), between 0.9
and 1.8 for peritumoral areas (P), and below 0.9 for host
normal areas (H). Figure 1 shows an example of the H,
P and T areas chosen as well as the proliferation rate
measured using the Ki67 staining. In particular, Ki67, an
Figure 1 Proliferation profiles assessed by Ki67 immunostaining in host, peritumor and tumor fractions obtained by neuronavigation.
Spectroscopic Cho/NAA ratios were evaluated in all voxels of a predetermined axial slice during the MRI examination. Voxels with low,
intermediate and high Cho/NAA ratio were chosen to obtain host, peritumor and tumor fractions as described in Methods. Cell proliferation
indices for each fraction were determined using immunostaining with Ki67. The percentage of Ki67-positive cells is indicated in each image. H:
host tissue; P: peritumor tissue; T: tumor tissue.
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cells of the host tissue; this percentage went up to 15%
i nt h ep e r i t u m o rt i s s u ea n dr e a c h e d3 0 %i nt h et u m o r
tissue (Figure 1). Importantly, these fractions with
increasing Cho/NAA ratios and Ki67 expression were
used throughout the study to asses changes of expres-
sion of the molecules analyzed.
Expression and localization of HIF-1a and NF-kB in the
glioblastoma tumor microenvironment
Figure 2A shows expression levels of HIF-1a in nuclear
and cytosolic fractions in host, peritumor and tumor
tissues obtained as described in Figure 1. An increase in
HIF-1a levels was observed in both nuclear and cytoso-
lic fractions from tumor tissue, and only in the cytosolic
fraction of peritumor tissue when compared to host tis-
sue. However, only in the tumor tissue was such an
increase statistically significant. A similar result was
obtained by studying the binding capacity of nuclear
HIF-1a by Trans-AM ELISA assay. Figure 2B shows an
increase in nuclear HIF-1a bound to HRE-containing
oligonucleotides in tumor versus host or peritumor
tissue. No differences were observed between host and
peritumor tissues. Finally,t h eh y p o x i cs i g n a t u r ew a s
determined by measuring mRNA expression levels for
VEGF, EPO and GLUT1. Figure 2B, right side, shows
that these three known target genes of HIF-1a were
up-regulated only in the tumor tissue.
NF-kB is a transcription factor lying at the crossroads
of inflammation, tumor transformation, response to
hypoxia, etc. We, therefore, studied the expression of
NF-kB in cytosolic and nuclear fractions of host, peritu-
mor and tumor samples obtained using the neuronavi-
gator. Figure 2C shows a significantly increased
expression of NF-kB in the nuclei of peritumor and
tumor samples when compared to host tissue. A signifi-
cant increase in NF-kB was observed only in the cytoso-
lic fraction of the peritumor tissue (Figure 2C).
Pro-inflammatory gene expression in the glioblastoma
tumor microenvironment
mRNA expression of genes involved in the inflammatory
response in tissue samples from host, tumor and peritu-
mor samples of glioblastoma tumors was analyzed by
RT-PCR. Figure 3 shows expression levels for the
alarmin or DAMP receptors RAGE and P2X7R, for the
inducible enzymes COX2 and NOS2, and for the acute
phase protein PTX3. mRNA expression of the mem-
brane receptors RAGE and P2X7R was up-regulated in
tumor versus host tissue. Figure 3 also shows that
mRNA expression of COX2 was up-regulated in tumor
tissues, whereas no change was observed when compar-
ing peritumor and host tissue. By contrast, NOS2
mRNA showed a pattern of increasing up-regulation
from peritumor to tumor tissue compared to the host
tissue. Finally, PTX3 mRNA was increasingly up-
regulated from peritumor to tumor tissue in comparison
to expression levels in host tissue (Figure 3).
Pro-inflammatory protein expression in the glioblastoma
tumor microenvironment
Figure 4A shows expression levels for the pro-inflamma-
tory proteins P2X7R, RAGE, NOS2, COX2 and PTX3.
Separation of host, peritumor and tumor fractions from
glioblastoma samples obtained by neuronavigator
revealed an overexpression of all pro-inflammatory
proteins examined (Figure 4A) in the tumor fractions.
In fact, expression of the membrane receptors RAGE
and P2X7R was up-regulated in tumor versus peritumor
or host tissues (Figure 4A). The inducible enzymes
COX2 and NOS2 were up-regulated in both tumor and
peritumor tissue. However, the 250KDa form of NOS2
showed an increase only in tumor tissue (Figure 4A).
The acute phase protein PTX3 did not show any differ-
ences among the three tissue fractions examined (Figure
4A). Importantly, host and tumor fractions examined in
our study did not show any significant presence of
leukocytes as shown by CD45 staining in figure 4B.
Hypoxia regulates expression of pro-inflammatory genes
and proteins in glioblastoma stem cells
Cancer stem cells are represented by those cells within a
tumor that can self-renew and propagate new tumors
[13,14]. In particular, cancer stem cells have been
reported to be the only tumorigenic population in GBM
[15]. Therefore, we isolated undifferentiated GBM cells
from tumor biopsies in order to investigate if the over-
expression of pro-inflammatory proteins observed in
tumor fractions was also present in this population.
Two different GBM stem cells populations, called GBM-
M and GBM-Q, were isolated from biopsies from two
separate tumors. Both GBM-M and Q grew as tumor
spheres and showed similar responses to hypoxia as
shown below. Furthermore, they were characterized by
measuring both stem cell and differentiation-related
markers. Figure 5A shows that the stem cell/progenitor
marker CD133 was expressed only in GBM-M spheres.
When GBM-M stem cells were differentiated for 1
week, CD133 expression was undetectable (Figure 5A).
By contrast, expression of the astrocytic marker glial
fibrillary acid protein (GFAP), was expressed in differen-
tiated but not in stem GBM-M cells (Figure 5B). Similar
results were obtained with the GBM-Q population (not
shown).
We have previously shown that hypoxia increases
expression of pro-inflammatory proteins in prostate and
breast tumor cells [10,11]. Therefore, GBM stem cells
were incubated under hypoxic conditions. Figure 6A
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Page 6 of 16Figure 2 HIF-1a and NF-kB expression in host, peritumor and tumor fractions obtained by neuronavigation. (A) Host (H), peritumor (P)
and tumor (T) tissues of GBM were obtained by neuronavigation. The content of HIF-1a was determined by western blotting. Values obtained
from densitometric analyses of cytosolic and nuclear fractions from all samples analyzed (10) are shown. b-Actin and Lamin A/C were used as
loading controls for the cytosolic and nuclear fractions, respectively. Data are presented as mean ± SD for all GBMs analyzed (n = 10). *, P < 0.05.
(B) Left side: Host (H), peritumor (P) and tumor (T) tissue of GBM were obtained by neuronavigation. HIF-1a content was measured in the
nuclear fractions by Trans-AM ELISA assay as described in Methods. Right side: VEGF, EPO and GLUT1 mRNA expression was measured in H, P
and T tissues by RT-PCR. Data are presented as mean ± SD for all GBMs analyzed (n = 10). *, P < 0.05.(C) Host (H), peritumor (P) and tumor (T)
tissues of GBM were obtained by neuronavigation. Content of the NF-kB subunit p65 was determined by western blotting. Values obtained from
densitometric analysis of cytosolic and nuclear fractions from all samples analyzed (n = 10) are shown. b-Actin and Lamin A/C were used as
loading controls for the cytosolic and nuclear fractions, respectively. Data are presented as mean ± SD for all GBMs analyzed (n = 10). *, P < 0.05.
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reduce their growth rate when incubated under
hypoxia. However, tumor spheres survive up to 5 days
of hypoxia without showing any sign of necrosis
(Figure 6A). The major transcription factor activated
by hypoxia is HIF-1a. Figure 6B show sections of
spheres incubated either in normoxia (C) or hypoxia
for 17 h. HIF-1a was expressed in the stem cells
forming the GBM tumor spheres. Hypoxia incubation
clearly increased HIF-1a expression and nuclear accu-
mulation (Figure 6B).
Figure 7A shows that hypoxia influenced the expres-
sion of pro-inflammatory genes and proteins in GBM
stem cells. In fact, mRNA expression for HIF-1a, NF-kB,
RAGE, P2X7R, COX2, and CXCR4 was increased when
stem cell spheres were incubated in hypoxia for 2, 6 and
24 h (Figure 7A). VEGF, a HIF-1a target gene, was
increased after 24 h of hypoxia following a peculiar initial
decrease at 2 and 6 h (Figure 7A). By contrast, PTX3
mRNA expression was not influenced by hypoxia (Figure
7A). The binding capacity of HIF-1a to HRE, measured
by ELISA, showed an initial increase after 2 and 6 h of
hypoxia, and a subsequent decrease at 24 h as shown in
figure 7B. Both GBM-M and GBM-Q were assessed with
similar results (Figure 7B). Figure 7C shows that
GBM-M stem cells spheres express transcription factors
such as HIF-1a and NF-kB as well as the pro-inflamma-
tory proteins RAGE, P2X7R, COX2 and PTX3, and the
chemokine (C-X-C motif) receptor 4 (CXCR4). Hypoxia
increased the expression of HIF-1a at 6 h and NF-kB at
24 h. The expression of COX2, RAGE, P2X7R and PTX3
was increased after 6 h of hypoxia (Figure 7C) but
showed a reduction after 24 h of hypoxia, a time point
where HIF-1a expression was also significantly reduced.
Finally, 24 h of hypoxia increased the expression levels of
CXCR4 (Figure 7C). Interestingly, when GBM-M stem
cells were differentiated for 1 week and then incubated
under hypoxia, expression of the proteins examined was
reduced. In fact, HIF-1a was not detected in normoxic
cells as it was in the tumor spheres, but was still induced
by hypoxia. NF-kB expression did not change between
normoxic and hypoxic cells. The membrane receptor
RAGE was expressed at lower levels and showed a
low induction by hypoxia. The other membrane receptor
P2X7R was present but not influenced by hypoxia.
The inducible enzyme, COX2 was increased after 6 h
of hypoxia, in a manner similar to what was observed in
the stem cells. Finally, CXCR4 was barely detectable in
differentiated cells and was not induced by hypoxia
(Figure 7C).
Figure 3 mRNA expression levels of pro-inflammatory genes in host, peritumor and tumor fractions obtained by neuronavigation.
Host (H), peritumor (P) and tumor (T) tissues of GBM were obtained by neuronavigation. Each fraction was processed and mRNA obtained as
described in Methods. mRNA expression levels for RAGE, P2X7R, COX2, NOS2 and PTX3 were determined by real time PCR. The bar graphs show
fold increases in expression of the studied molecules in peritumor and tumor tissue with respect to host tissue, set at 0. Data are presented as
mean ± SD for all GBMs analyzed (n = 10). *, P < 0.05.
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Page 8 of 16Figure 4 Protein expression levels of pro-inflammatory molecules from host, peritumor and tumor fractions obtained by
neuronavigation. (A) Host (H), peritumor (P) and tumor (T) tissues of GBM were obtained by neuronavigation and protein expression levels of
pro-inflammatory molecules were measured using western blotting. Values obtained from densitometric analysis of RAGE, P2X7R, COX2, NOS2
and PTX3 in tumor and peritumor tissues with respect to host cells from each biopsy are expressed as arbitrary units in each graph. A
representative western blot for each molecule is shown on the left side. b-Actin was used as a loading control. (B) Host (H), peritumor (P) and
tumor (T) tissues of GBM were obtained by neuronavigation. Content of the pan-leukocyte marker, CD45, was determined by SDS-PAGE and
western blotting. A positive control for the antibody, represented by white cells isolated from a blood sample, is shown in the left lane.
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Page 9 of 16Hypoxia increases invasion and migration of
glioblastoma stem cells
Expression of membrane receptors such as CXCR4, a
Gi protein-coupled receptor for the ligand CXCL12/
stromal cell-derived factor 1a (SDF-1a), has been asso-
ciated with increased proliferation, invasion and migra-
tion in GBM as well as in several other tumors and
tumor cell lines [18,19]. Figure 8 shows that both
GBM-M and GBM-Q stem cells showed an invasive
and migratory basal capacity measured after 48 h of
normoxic incubation that was not increased by SDF-
1a addition. Incubation of GBM stem cells under
hypoxia for 24 h followed by 24 h of normoxia pro-
duced an increase in the number of invading and
migrating cells. In this case, SDF-1a treatment during
24 h of normoxia incubation significantly increased the
Figure 5 Molecular characterization of stem and differentiated GBM cells. (A) GBM stem cell spheres were stained with PE and CD133-PE
and then processed by flow cytometry. (B) Differentiated GBM stem cells were immunostained for GFAP followed by anti-rabbit alexa 488.
Nuclei were stained with DAPI. Immunofluorescence was analyzed by confocal microscopy.
Tafani et al. Journal of Neuroinflammation 2011, 8:32
http://www.jneuroinflammation.com/content/8/1/32
Page 10 of 16Figure 6 Hypoxia influences growth and HIF-1a activation in cancer stem cells from GBM. (A) GBM tumor spheres were grown either
under normoxia or hypoxia for 2 or 5 days. Images of the tumor spheres were then taken using a digital camera mounted on an EclipseNet
2000 microscope. C: control normoxic cells. (B) GBM tumor spheres were grown either under normoxia or hypoxia for 17 h. Upper panel:
Integrity of spheres was assessed in sections by hematoxylin/eosin staining. Lower panel: HIF-1a expression in sphere sections was studied by
immunofluorescence as described in Methods. C: control normoxic cells.
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Page 11 of 16Figure 7 mRNA and protein expressions of pro-inflammatory proteins in hypoxic cancer stem cells from GBM. (A) GBM stem cells were
incubated under hypoxic conditions for 6 and 24 h. After the times indicated, the cells were processed and mRNA obtained as described in
Methods. mRNA expression levels for HIF-1a, NF-kB, RAGE, P2X7R, COX2, NOS2, PTX3, CXCR4 and VEGF were determined using real time PCR.
The bar graphs show fold increases in expression of the studied molecules in cancer cells with respect to control normoxic cells, set at 0. Data
are presented as mean ± SD for three separate experiments, each repeated in triplicate. *, P < 0.05.(B) GBM-M and -Q stem cells were incubated
under normoxia or hypoxia for the times indicated. HIF-1a content was measured in nuclear fractions by Trans-AM ELISA assay as described in
Methods. *, P < 0.05.(C) GBM-M stem and differentiated cells were incubated under hypoxic conditions for 6 or 24 h. After the times indicated,
cells were processed as described in Methods. Contents of HIF-1a, NF-kB, RAGE, P2X7R, COX2, PTX3 and CXCR4 were determined by western
blotting. b-Actin was used as a loading control. Blots are representative of at least three separate experiments. C: control normoxic cells.
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Page 12 of 16number of invading GBM stem cells (Figure 8). Finally,
differentiation of GBM-M and Q stem cells signifi-
cantly reduced their invasive capacities under hypoxia
and hypoxia plus SDF-1a (Figure 8).
Discussion
We have recently shown that a pro-inflammatory repara-
tive response is activated in tumor samples of prostate
and breast carcinomas in the absence of a leukocyte
infiltrate [10,11]. In particular, tumor and host cells from
these tumor samples, isolated by laser capture microdis-
section (LCMD), show an increased and coordinated
expression of several pro-inflammatory proteins only in
tumor cells [11]. Moreover, in the MCF-7 breast cancer
cell line, we demonstrated that hypoxia stimulates coor-
dinated expression of the same set of molecules observed
Figure 8 Hypoxia increases invasion of cancer stem cells from GBM.G B Ms t e ma n dd i f f e r e n t i a t e dc e l ls were incubated under normoxic
conditions for 48 h. Alternatively, differentiated and stem cells were incubated under hypoxia for 24 h followed by 24 h of normoxia in the presence
or absence of 100 ng/ml SDF-1a. Invading cells were stained and lysed as described in Methods. *, P < 0.05. N: normoxia. H: hypoxia. SDF: SDF-1a
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Page 13 of 16in the tumor samples with an increase in cellular invasion
and migration [11].
GBMs are malignant and fast growing tumors charac-
terized by the presence of hypoxia that causes central
necrosis and vascular proliferation, which are two diag-
nostic criteria for these tumors [20]. Recently, it has
been postulated that proliferation and maintenance of
GBMs are due to the presence of populations of cancer
stem cells with self-renewal and tumorigenic properties
[15]. In the present study we aimed to show that in
GBM hypoxia and necrosis determine and maintain the
expression of a coordinated pro-inflammatory response
that is particularly important for tumor transformation
and progression. Furthermore, we also hypothesized that
such a pro-inflammatory response would be clearly
present in the cancer stem cell population.
In the case of the GBMs from ten different patients,
the surgical procedure using the neuronavigation system
allowed us to obtain tumor, peritumor and host tissue
samples. Analysis and comparison of these samples
showed differential expression and subcellular accumu-
lation of both hypoxia-regulated transcription factors
HIF-1a and NF-kB and of several pro-inflammatory
molecules (Figure 1, 2 and 3). None of the GBM sam-
ples we analyzed showed the presence of a leukocyte
infiltrate as indicated by the absence of CD45 by wes-
t e r nb l o t( F i g u r e4 B ) .W ea c k n o w l e d g et h ep o s s i b i l i t y
that microglia could also contribute to the pro-inflam-
matory genes expression we observed. In fact, by immu-
nohistochemistry we could measure weak CD68 staining
in the host, peritumor and tumor tissues examined (not
shown). However, given the fact that CD68 staining is
weak in tumor samples and that GBM stem cells show a
pro-inflammatory gene expression, we believe that other
cell types can, under hypoxia, also activate expression of
pro-inflammatory genes. The presence of microglia in
these samples raises also another important point,
which is the importance of inflammatory cells for tumor
progression. In fact, inflammatory cells, particularly
macrophages, are an important part of the physiological
response to the tumor. These cells are important for
both tumor transformation and progression. However,
we suggest that, in order to have tumor progression,
another important player must be present. Such a player
is represented by the expression by transformed tumor
cells of pro-inflammatory proteins that allow them to
survive, invade and migrate following a chemical
gradient.
Both HIF-1a and NF-kB expression has been reported
to be controlled by hypoxia [21]. However, the precise
mechanisms and, most of all, the correlations between
these two transcription factors are still obscure with
some reports showing an activation of NF-kB by HIF-1a
and others showing the opposite [22,23]. Our molecular
analysis of tumor samples shows that HIF-1a is
over-expressed and accumulates in the nucleus of the
tumor fraction compared to the peritumor or host frac-
tions (Figure 2A,B). We also observed that NF-kB
expression increased in the nuclear and cytosolic frac-
tions of peritumor tissue, and in the cytosolic fraction of
tumor tissue (Figure 2C). Moreover, hypoxic incubation
of cancer stem cells isolated from GBM revealed that
HIF-1a and NF-kB have different time courses of activa-
tion within the first 24 h. In fact, HIF-1a expression is
increased after 6 h of hypoxia and decreased at 24 h. By
contrast, NF-kB expression is decreased after 6 h and
increased after 24 h of hypoxia. Interestingly, the time
courses of activation of pro-inflammatory proteins
analyzed in hypoxic cancer stem cells were similar to
that of HIF-1a, with an increase after 6 h and a
decrease after 24 h. This result indicates that, at least
during the first 24 h, pro-inflammatory proteins expres-
sion is influenced by hypoxia.
Analysis of pro-inflammatory phenotype in tumor
samples and in cancer stem cells from GBM was con-
ducted at the mRNA and protein levels by studying
the expression of the membrane receptors RAGE and
P2X7R, the inducible enzymes COX2 and NOS2, and
the acute phase protein PTX3. Increased expression of
RAGE and its ligand HMGB1 is usually observed in
metastatic tumors and has been associated with inva-
sion and poor prognosis [24-26]. Similarly, our results
show that RAGE is clearly overexpressed in GBM
tumor fractions (high Ki67 and Co/NAA) both at the
mRNA and protein levels (Figure 3 and 4A). Further-
more, cancer stem cells isolated from GBM and incu-
bated under hypoxia show an overexpression of RAGE
w i t hat i m ec o u r s er e s e m b l i n gt h a to fH I F - 1 a.T h i s
result indicates that, as previously shown by us in
other cell lines [11], RAGE expression is controlled by
hypoxia. It is worth noting that cancer stem cells have
an elevated basal expression level of RAGE resembling
that of the tumor fraction isolated during neuronaviga-
tion surgery, and that differentiation of GBM stem
cells reduces expression of RAGE both in normoxia
and in hypoxia. The purinergic receptor P2X7R has
been less studied in GBMs or in glioma cell lines, and
such studies have yielded the most disparate results. In
fact, some reports have shown that C6 mouse glioma
cells do not express P2X7R [27], whereas other reports
have shown the opposite along with an important role
for P2X7R in increasing tumor cell migration [28].
Furthermore, the role of P2X7R in tumor cell biology
is not well understood because some results have
shown a cytotoxic effect in the presence of ATP [29],
whereas other results have shown a survival effect
[30,31]. Finally, it has also been shown that glioma
cells are more resistant to ATP toxicity when
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could contribute to invasion of tumor cells [32]. Our
results, using host, peritumor and tumor fractions of
GBM, have shown up-regulation of P2X7R mRNA and
protein only in tumor tissue. Interestingly, this same
up-regulation was observed in cancer stem cells from
GBM in the presence of hypoxia. We do not know the
precise role of such P2X7R up-regulation, however, by
silencing P2X7R in other tumor cell lines we have
observed a reduction of cell motility and invasion
(Russo, personal communications). It should also be
pointed out that in those reports showing ATP toxicity
through P2X7R activation, cell death is not apoptotic
but necrotic, with release of DAMPs that can, in turn,
activate NF-kB-dependent survival pathways in the
surviving tumor cells.
The inducible enzymes COX2 and NOS2 were overex-
pressed in peritumor and tumor tissue from GBM and,
in the case of cancer stem cells, COX2 expression was
increased by hypoxia. These results are in agreement
with those obtained by other groups showing an up-
r e g u l a t i o no fC O X 2a n dN O S 2t h a tm a yc o n t r i b u t et o
the formation of new vessels and may represent prognos-
tic factors [33].
PTX3 is produced and exposed on tissue cells and is
considered a mediator of innate immunity and inflam-
mation [34]. However, although it is well known that
CRP is increased in tumor-bearing patients, probably
because of the inflammatory reaction to the tumor pre-
sence, nobody has explored if the production of long-
pentraxins and other acute phase proteins could be also
due to the tumor cells themselves in response to
hypoxia. In this regard, our results show that GBMs and
cancer stem cells express PTX3. However, such expres-
sion is not upregulated in tumor compared to peritumor
or host tissue, and is only mildly influenced by hypoxia.
Finally, we have also observed, as reported by other
groups, an up-regulation of the receptor for CXC che-
mokines CXCR-4 in hypoxic GBM stem cells that is
clearly present after 24 h of hypoxia (Figure 7C). The
biological effect of this up-regulation is the increased
ability of hypoxic GBM stem cells to migrate along an
SDF-1a gradient. It is worth noting that differentiation
of GBM stem cells strongly reduces CXCR4 expression
levels as well as migration in the presence of hypoxia or
hypoxia plus SDF-1a (Figure 7C and 8). These results
validate our hypothesis that, compared to differentiated
tumor cells, GBM cancer stem cells have a high capacity
to respond to hypoxia by activating expression of pro-
inflammatory genes that, in turn, confer upon these
cells the ability to adapt and survive under such stressful
conditions.
Conclusions
Our study indicates that hypoxia activates a coordinated
up-regulation of pro-inflammatory proteins in GBMs.
Such up-regulation is particularly evident in tumor
tissue when compared to peritumor and host tissue. A
similar coordinated up-regulation is observed in GBM
cancer stem cells under hypoxia and is strongly reduced
when these cells are differentiated. Therefore, we can
conclude that hypoxia due to the rapid growth observed
in GBMs causes the expression of pro-inflammatory
proteins that, in turn, allow tumor stem cells to activate
molecular survival pathways in response to necrotic
cell death.
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